Flow Cytometry-Based Characterization of Mast Cells in Human Atherosclerosis
The presence of mast cells in human atherosclerotic plaques has been associated with adverse cardiovascular events. Mast cell activation, through the classical antigen sensitized-IgE binding to their characteristic Fcε-receptor, causes the release of their cytoplasmic granules. These granules are fi...
Uložené v:
| Vydané v: | Cells (Basel, Switzerland) Ročník 8; číslo 4; s. 334 |
|---|---|
| Hlavní autori: | , , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
Switzerland
MDPI AG
09.04.2019
MDPI |
| Predmet: | |
| ISSN: | 2073-4409, 2073-4409 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | The presence of mast cells in human atherosclerotic plaques has been associated with adverse cardiovascular events. Mast cell activation, through the classical antigen sensitized-IgE binding to their characteristic Fcε-receptor, causes the release of their cytoplasmic granules. These granules are filled with neutral proteases such as tryptase, but also with histamine and pro-inflammatory mediators. Mast cells accumulate in high numbers within human atherosclerotic tissue, particularly in the shoulder region of the plaque. These findings are largely based on immunohistochemistry, which does not allow for the extensive characterization of these mast cells and of the local mast cell activation mechanisms. In this study, we thus aimed to develop a new flow-cytometry based methodology in order to analyze mast cells in human atherosclerosis. We enzymatically digested 22 human plaque samples, collected after femoral and carotid endarterectomy surgery, after which we prepared a single cell suspension for flow cytometry. We were able to identify a specific mast cell population expressing both CD117 and the FcεR, and observed that most of the intraplaque mast cells were activated based on their CD63 protein expression. Furthermore, most of the activated mast cells had IgE fragments bound on their surface, while another fraction showed IgE-independent activation. In conclusion, we are able to distinguish a clear mast cell population in human atherosclerotic plaques, and this study establishes a strong relationship between the presence of IgE and the activation of mast cells in advanced atherosclerosis. Our data pave the way for potential therapeutic intervention through targeting IgE-mediated actions in human atherosclerosis. |
|---|---|
| AbstractList | The presence of mast cells in human atherosclerotic plaques has been associated with adverse cardiovascular events. Mast cell activation, through the classical antigen sensitized-IgE binding to their characteristic Fcε-receptor, causes the release of their cytoplasmic granules. These granules are filled with neutral proteases such as tryptase, but also with histamine and pro-inflammatory mediators. Mast cells accumulate in high numbers within human atherosclerotic tissue, particularly in the shoulder region of the plaque. These findings are largely based on immunohistochemistry, which does not allow for the extensive characterization of these mast cells and of the local mast cell activation mechanisms. In this study, we thus aimed to develop a new flow-cytometry based methodology in order to analyze mast cells in human atherosclerosis. We enzymatically digested 22 human plaque samples, collected after femoral and carotid endarterectomy surgery, after which we prepared a single cell suspension for flow cytometry. We were able to identify a specific mast cell population expressing both CD117 and the FcεR, and observed that most of the intraplaque mast cells were activated based on their CD63 protein expression. Furthermore, most of the activated mast cells had IgE fragments bound on their surface, while another fraction showed IgE-independent activation. In conclusion, we are able to distinguish a clear mast cell population in human atherosclerotic plaques, and this study establishes a strong relationship between the presence of IgE and the activation of mast cells in advanced atherosclerosis. Our data pave the way for potential therapeutic intervention through targeting IgE-mediated actions in human atherosclerosis. The presence of mast cells in human atherosclerotic plaques has been associated with adverse cardiovascular events. Mast cell activation, through the classical antigen sensitized-IgE binding to their characteristic Fcε-receptor, causes the release of their cytoplasmic granules. These granules are filled with neutral proteases such as tryptase, but also with histamine and pro-inflammatory mediators. Mast cells accumulate in high numbers within human atherosclerotic tissue, particularly in the shoulder region of the plaque. These findings are largely based on immunohistochemistry, which does not allow for the extensive characterization of these mast cells and of the local mast cell activation mechanisms. In this study, we thus aimed to develop a new flow-cytometry based methodology in order to analyze mast cells in human atherosclerosis. We enzymatically digested 22 human plaque samples, collected after femoral and carotid endarterectomy surgery, after which we prepared a single cell suspension for flow cytometry. We were able to identify a specific mast cell population expressing both CD117 and the FcεR, and observed that most of the intraplaque mast cells were activated based on their CD63 protein expression. Furthermore, most of the activated mast cells had IgE fragments bound on their surface, while another fraction showed IgE-independent activation. In conclusion, we are able to distinguish a clear mast cell population in human atherosclerotic plaques, and this study establishes a strong relationship between the presence of IgE and the activation of mast cells in advanced atherosclerosis. Our data pave the way for potential therapeutic intervention through targeting IgE-mediated actions in human atherosclerosis.The presence of mast cells in human atherosclerotic plaques has been associated with adverse cardiovascular events. Mast cell activation, through the classical antigen sensitized-IgE binding to their characteristic Fcε-receptor, causes the release of their cytoplasmic granules. These granules are filled with neutral proteases such as tryptase, but also with histamine and pro-inflammatory mediators. Mast cells accumulate in high numbers within human atherosclerotic tissue, particularly in the shoulder region of the plaque. These findings are largely based on immunohistochemistry, which does not allow for the extensive characterization of these mast cells and of the local mast cell activation mechanisms. In this study, we thus aimed to develop a new flow-cytometry based methodology in order to analyze mast cells in human atherosclerosis. We enzymatically digested 22 human plaque samples, collected after femoral and carotid endarterectomy surgery, after which we prepared a single cell suspension for flow cytometry. We were able to identify a specific mast cell population expressing both CD117 and the FcεR, and observed that most of the intraplaque mast cells were activated based on their CD63 protein expression. Furthermore, most of the activated mast cells had IgE fragments bound on their surface, while another fraction showed IgE-independent activation. In conclusion, we are able to distinguish a clear mast cell population in human atherosclerotic plaques, and this study establishes a strong relationship between the presence of IgE and the activation of mast cells in advanced atherosclerosis. Our data pave the way for potential therapeutic intervention through targeting IgE-mediated actions in human atherosclerosis. |
| Author | Depuydt, Marie A.C. de Vries, Margreet R. Kuiper, Johan Smeets, Harm J. van Duijn, Janine Foks, Amanda C. Slütter, Bram Mulder, Kevin E. Smit, Marrit D. Govaert, Arthur M. Quax, Paul H.A. Kritikou, Eva Wezel, Anouk Bot, Ilze |
| AuthorAffiliation | 2 Department of Surgery, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands; m.r.de_vries@lumc.nl (M.R.d.V.); a.m.govaert@lumc.nl (A.M.G.); m.d.smit@lumc.nl (M.D.S.); p.h.a.quax@lumc.nl (P.H.A.Q.) 4 Department of Surgery, HMC Westeinde, 2512 VA The Hague, The Netherlands; a.wezel@haaglandenmc.nl (A.W.); h.smeets@haaglandenmc.nl (H.J.S.) 1 Division of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The Netherlands; e.kritikou@lacdr.leidenuniv.nl (E.K.); m.a.c.depuydt@lacdr.leidenuniv.nl (M.A.C.D.); kevin.evan@hotmail.com (K.E.M.); j.van.duijn@lacdr.leidenuniv.nl (J.v.D.); a.c.foks@lacdr.leidenuniv.nl (A.C.F.); b.a.slutter@lacdr.leidenuniv.nl (B.S.); j.kuiper@lacdr.leidenuniv.nl (J.K.) 3 Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands |
| AuthorAffiliation_xml | – name: 2 Department of Surgery, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands; m.r.de_vries@lumc.nl (M.R.d.V.); a.m.govaert@lumc.nl (A.M.G.); m.d.smit@lumc.nl (M.D.S.); p.h.a.quax@lumc.nl (P.H.A.Q.) – name: 3 Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands – name: 4 Department of Surgery, HMC Westeinde, 2512 VA The Hague, The Netherlands; a.wezel@haaglandenmc.nl (A.W.); h.smeets@haaglandenmc.nl (H.J.S.) – name: 1 Division of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The Netherlands; e.kritikou@lacdr.leidenuniv.nl (E.K.); m.a.c.depuydt@lacdr.leidenuniv.nl (M.A.C.D.); kevin.evan@hotmail.com (K.E.M.); j.van.duijn@lacdr.leidenuniv.nl (J.v.D.); a.c.foks@lacdr.leidenuniv.nl (A.C.F.); b.a.slutter@lacdr.leidenuniv.nl (B.S.); j.kuiper@lacdr.leidenuniv.nl (J.K.) |
| Author_xml | – sequence: 1 givenname: Eva surname: Kritikou fullname: Kritikou, Eva – sequence: 2 givenname: Marie A.C. orcidid: 0000-0002-7174-1952 surname: Depuydt fullname: Depuydt, Marie A.C. – sequence: 3 givenname: Margreet R. orcidid: 0000-0002-3648-9130 surname: de Vries fullname: de Vries, Margreet R. – sequence: 4 givenname: Kevin E. surname: Mulder fullname: Mulder, Kevin E. – sequence: 5 givenname: Arthur M. surname: Govaert fullname: Govaert, Arthur M. – sequence: 6 givenname: Marrit D. surname: Smit fullname: Smit, Marrit D. – sequence: 7 givenname: Janine surname: van Duijn fullname: van Duijn, Janine – sequence: 8 givenname: Amanda C. surname: Foks fullname: Foks, Amanda C. – sequence: 9 givenname: Anouk surname: Wezel fullname: Wezel, Anouk – sequence: 10 givenname: Harm J. surname: Smeets fullname: Smeets, Harm J. – sequence: 11 givenname: Bram surname: Slütter fullname: Slütter, Bram – sequence: 12 givenname: Paul H.A. orcidid: 0000-0002-6853-5760 surname: Quax fullname: Quax, Paul H.A. – sequence: 13 givenname: Johan surname: Kuiper fullname: Kuiper, Johan – sequence: 14 givenname: Ilze orcidid: 0000-0002-1242-1959 surname: Bot fullname: Bot, Ilze |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30970663$$D View this record in MEDLINE/PubMed |
| BookMark | eNptkk1P3DAQhq2KqtAtt56rSL1waFonjj9yqUQjKEiLemnP1sQfrFdJTG2Havn1eFmKFoQPtmU_83o877xHB5OfDEIfK_yVkBZ_U2YYosANJqR5g45qzEnZNLg92NsfouMY1zgPUbEK03fokOCWY8bIEVqeD_5f0W2SH00Km_IHRKOLbgUBVDLB3UFyfiq8La4gpqLbvle4qbiYR5iK07QywUc1bGcXP6C3FoZojh_XBfpzfva7uyiXv35edqfLUjVcpJIaa6y1oBUBLYgF2veYcVC0YpwosK0WlClSY8Og15hUqrGG973WnPVMkAW63OlqD2t5E9wIYSM9OPlw4MO1hJBcTkv2lPStymLamkaDapVWNcOMal0zwaus9X2ndTP3o9HKTCnA8Ez0-c3kVvLa30pGayJyDRfo5FEg-L-ziUmOLm59gcn4Oco6G9FSygXP6OcX6NrPYcqlkjVtBKk5ozRTn_Yzekrlv2kZ-LIDVK56DMY-IRWW27aQ-22R8foFrlx6sDX_xw2vB90DOrm9cg |
| CitedBy_id | crossref_primary_10_1016_j_atherosclerosis_2024_118560 crossref_primary_10_3389_fimmu_2025_1527129 crossref_primary_10_1016_j_ejvs_2021_07_008 crossref_primary_10_1016_j_atherosclerosis_2025_120509 crossref_primary_10_1016_j_allmed_2024_100003 crossref_primary_10_3390_nu15081850 crossref_primary_10_1007_s12016_024_08981_9 crossref_primary_10_2147_JIR_S294809 crossref_primary_10_3390_ijms20184479 crossref_primary_10_1016_j_vph_2023_107167 crossref_primary_10_3390_jcdd11020054 crossref_primary_10_1016_j_iac_2024_01_004 crossref_primary_10_3390_antiox11020233 crossref_primary_10_1007_s11883_020_00837_9 crossref_primary_10_1016_j_jaip_2024_03_010 crossref_primary_10_23736_S0392_9590_19_04250_0 crossref_primary_10_1016_j_biopha_2025_117860 crossref_primary_10_1186_s12951_023_01899_y crossref_primary_10_3390_ijms20143395 crossref_primary_10_3390_molecules24173072 crossref_primary_10_1007_s00441_022_03687_w crossref_primary_10_20538_1682_0363_2021_2_184_190 crossref_primary_10_1016_j_vph_2023_107172 crossref_primary_10_1093_cvr_cvae066 crossref_primary_10_1016_j_anai_2021_03_020 crossref_primary_10_1007_s12026_023_09438_5 crossref_primary_10_1016_j_jaci_2023_09_038 crossref_primary_10_3390_ijms23052547 crossref_primary_10_1002_ehf2_13793 crossref_primary_10_1016_j_actbio_2025_05_022 crossref_primary_10_1016_j_it_2020_06_006 crossref_primary_10_1016_j_forsciint_2023_111689 |
| Cites_doi | 10.1016/j.atherosclerosis.2017.01.022 10.1161/CIRCULATIONAHA.106.660472 10.1016/j.rmed.2011.09.007 10.1016/j.amjmed.2008.10.013 10.1016/j.ejphar.2015.07.017 10.1161/CIRCRESAHA.109.204875 10.1111/bph.12138 10.1016/j.jim.2014.12.010 10.1160/TH11-05-0291 10.1161/01.ATV.14.6.966 10.1161/01.CIR.0000144307.82502.32 10.1161/01.CIR.90.4.1669 10.1016/S1081-1206(10)62178-3 10.1016/0021-9150(95)05794-3 10.1161/01.STR.0000173153.51295.ee 10.1161/CIR.0000000000000485 10.7754/Clin.Lab.2016.160517 10.1016/j.atherosclerosis.2014.04.025 10.1016/j.anndiagpath.2012.04.007 10.1093/cvr/cvs312 10.3109/07853890.2014.927714 10.1038/nrcardio.2015.117 10.1016/j.yjmcc.2014.02.005 10.1097/01.mca.0000224420.67304.4d 10.1161/01.CIR.92.5.1084 10.1172/JCI46028 10.1371/journal.pone.0060960 10.1093/cvr/cvq260 10.1073/pnas.88.14.6382 10.1161/ATVBAHA.114.303570 10.1093/eurheartj/eht186 10.1084/jem.170.1.245 10.1016/j.atherosclerosis.2017.11.030 10.1016/j.atherosclerosis.2016.05.020 10.1159/000350102 10.4049/jimmunol.1202323 10.1016/0895-4356(95)00548-X |
| ContentType | Journal Article |
| Copyright | 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2019 by the authors. 2019 |
| Copyright_xml | – notice: 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2019 by the authors. 2019 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 8FD 8FE 8FH ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 GNUQQ HCIFZ LK8 M7P P64 PHGZM PHGZT PIMPY PKEHL PQEST PQGLB PQQKQ PQUKI PRINS RC3 7X8 5PM DOA |
| DOI | 10.3390/cells8040334 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Engineering Research Database ProQuest Central Student SciTech Premium Collection Biological Sciences Biological Science Database Biotechnology and BioEngineering Abstracts Proquest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences Genetics Abstracts Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Central (New) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Biological Science Database ProQuest SciTech Collection Biotechnology and BioEngineering Abstracts ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest One Academic (New) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE CrossRef Publicly Available Content Database MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ - Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: ProQuest Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 2073-4409 |
| ExternalDocumentID | oai_doaj_org_article_b53b9c6c3dfe4dac9cdc26065dd26871 PMC6523866 30970663 10_3390_cells8040334 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | United States--US Netherlands |
| GeographicLocations_xml | – name: Netherlands – name: United States--US |
| GroupedDBID | 53G 5VS 8FE 8FH AADQD AAFWJ AAYXX ABDBF ACUHS ADBBV AFFHD AFKRA AFPKN AFZYC ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BBNVY BCNDV BENPR BHPHI CCPQU CITATION DIK EBD ESX GROUPED_DOAJ HCIFZ HYE IAO KQ8 LK8 M48 M7P MODMG M~E OK1 PGMZT PHGZM PHGZT PIMPY PQGLB PROAC RPM CGR CUY CVF ECM EIF NPM 8FD ABUWG AZQEC DWQXO FR3 GNUQQ P64 PKEHL PQEST PQQKQ PQUKI PRINS RC3 7X8 5PM |
| ID | FETCH-LOGICAL-c478t-5efefffadc3ad83fa5bb067ac51673caf9d856c320e6abd031c4fe7bbdd76b683 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 30 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000467304300048&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2073-4409 |
| IngestDate | Fri Oct 03 12:52:52 EDT 2025 Tue Nov 04 01:43:39 EST 2025 Sun Nov 09 12:16:28 EST 2025 Fri Jul 25 11:50:34 EDT 2025 Thu Jan 02 22:58:37 EST 2025 Sat Nov 29 07:14:00 EST 2025 Tue Nov 18 20:46:09 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | atherosclerosis mast cell flow cytometry tryptase plaque stability |
| Language | English |
| License | Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c478t-5efefffadc3ad83fa5bb067ac51673caf9d856c320e6abd031c4fe7bbdd76b683 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Current address: Department of Pathology, Brigham and Women’s Hospital–Harvard Medical School, Boston, MA 02115, USA. |
| ORCID | 0000-0002-3648-9130 0000-0002-1242-1959 0000-0002-7174-1952 0000-0002-6853-5760 |
| OpenAccessLink | https://doaj.org/article/b53b9c6c3dfe4dac9cdc26065dd26871 |
| PMID | 30970663 |
| PQID | 2548327655 |
| PQPubID | 2032536 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_b53b9c6c3dfe4dac9cdc26065dd26871 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6523866 proquest_miscellaneous_2207955787 proquest_journals_2548327655 pubmed_primary_30970663 crossref_primary_10_3390_cells8040334 crossref_citationtrail_10_3390_cells8040334 |
| PublicationCentury | 2000 |
| PublicationDate | 20190409 |
| PublicationDateYYYYMMDD | 2019-04-09 |
| PublicationDate_xml | – month: 4 year: 2019 text: 20190409 day: 9 |
| PublicationDecade | 2010 |
| PublicationPlace | Switzerland |
| PublicationPlace_xml | – name: Switzerland – name: Basel |
| PublicationTitle | Cells (Basel, Switzerland) |
| PublicationTitleAlternate | Cells |
| PublicationYear | 2019 |
| Publisher | MDPI AG MDPI |
| Publisher_xml | – name: MDPI AG – name: MDPI |
| References | Bot (ref_2) 2015; 35 Guo (ref_17) 2016; 251 ref_12 Lovett (ref_25) 2004; 110 Kraft (ref_28) 2013; 191 Kaartinen (ref_5) 1994; 90 Ammi (ref_24) 2015; 417 Lippi (ref_31) 2014; 46 Yu (ref_19) 2016; 778 Finn (ref_39) 2013; 170 Bot (ref_37) 2007; 115 Ramos (ref_35) 2017; 258 Willems (ref_15) 2013; 34 Amin (ref_3) 2012; 106 Laske (ref_33) 2003; 91 Lagraauw (ref_38) 2014; 235 Burd (ref_26) 1989; 170 Langer (ref_30) 1996; 49 Ramalho (ref_8) 2013; 17 Kelley (ref_18) 2006; 315 Kovanen (ref_6) 1995; 92 Bot (ref_7) 2011; 106 Wang (ref_16) 2011; 121 Insull (ref_32) 2009; 122 Logsdon (ref_40) 2015; 388 Rohm (ref_14) 2016; 62 Sinkiewicz (ref_29) 2007; 14 Bot (ref_13) 2011; 89 Mayranpaa (ref_9) 2006; 17 Tsai (ref_27) 1991; 88 Shi (ref_4) 2015; 2 Indhirajanti (ref_36) 2018; 268 Meng (ref_20) 2013; 31 Bot (ref_22) 2010; 106 Kaartinen (ref_10) 1996; 123 Wang (ref_34) 2014; 72 Benjamin (ref_1) 2017; 135 Wezel (ref_21) 2013; 97 Kaartinen (ref_11) 1994; 14 Verhoeven (ref_23) 2005; 36 |
| References_xml | – volume: 258 start-page: 20 year: 2017 ident: ref_35 article-title: Coronary atherosclerosis and dilation in hyper IgE syndrome patients: Depiction by magnetic resonance vessel wall imaging and pathological correlation publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2017.01.022 – volume: 115 start-page: 2516 year: 2007 ident: ref_37 article-title: Perivascular mast cells promote atherogenesis and induce plaque destabilization in apolipoprotein E-deficient mice publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.106.660472 – volume: 106 start-page: 9 year: 2012 ident: ref_3 article-title: The role of mast cells in allergic inflammation publication-title: Respir. Med. doi: 10.1016/j.rmed.2011.09.007 – volume: 122 start-page: S3 year: 2009 ident: ref_32 article-title: The pathology of atherosclerosis: Plaque development and plaque responses to medical treatment publication-title: Am. J. Med. doi: 10.1016/j.amjmed.2008.10.013 – volume: 778 start-page: 33 year: 2016 ident: ref_19 article-title: Non-IgE mediated mast cell activation publication-title: Eur. J. Pharmacol. doi: 10.1016/j.ejphar.2015.07.017 – volume: 106 start-page: 89 year: 2010 ident: ref_22 article-title: The neuropeptide substance P mediates adventitial mast cell activation and induces intraplaque hemorrhage in advanced atherosclerosis publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.109.204875 – volume: 170 start-page: 23 year: 2013 ident: ref_39 article-title: Twenty-first century mast cell stabilizers publication-title: Br. J. Pharmacol. doi: 10.1111/bph.12138 – volume: 417 start-page: 76 year: 2015 ident: ref_24 article-title: Fluorescent activated cell sorting: An effective approach to study dendritic cell subsets in human atherosclerotic plaques publication-title: J. Immunol. Methods doi: 10.1016/j.jim.2014.12.010 – volume: 106 start-page: 820 year: 2011 ident: ref_7 article-title: Mast cells in atherosclerosis publication-title: Thromb. Haemost. doi: 10.1160/TH11-05-0291 – volume: 14 start-page: 966 year: 1994 ident: ref_11 article-title: Mast cells of two types differing in neutral protease composition in the human aortic intima. Demonstration of tryptase- and tryptase/chymase-containing mast cells in normal intimas, fatty streaks, and the shoulder region of atheromas publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/01.ATV.14.6.966 – volume: 110 start-page: 2190 year: 2004 ident: ref_25 article-title: Histological correlates of carotid plaque surface morphology on lumen contrast imaging publication-title: Circulation doi: 10.1161/01.CIR.0000144307.82502.32 – volume: 90 start-page: 1669 year: 1994 ident: ref_5 article-title: Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture publication-title: Circulation doi: 10.1161/01.CIR.90.4.1669 – volume: 14 start-page: 266 year: 2007 ident: ref_29 article-title: Immunoglobulin E as a marker of the atherothrombotic process in patients with acute myocardial infarction publication-title: Cardiol. J. – volume: 91 start-page: 202 year: 2003 ident: ref_33 article-title: Extraordinarily high serum IgE levels and consequences for atopic phenotypes publication-title: Ann. Allergy. Asthma Immunol. doi: 10.1016/S1081-1206(10)62178-3 – volume: 123 start-page: 123 year: 1996 ident: ref_10 article-title: Mast cells accompany microvessels in human coronary atheromas: Implications for intimal neovascularization and hemorrhage publication-title: Atherosclerosis doi: 10.1016/0021-9150(95)05794-3 – volume: 36 start-page: 1735 year: 2005 ident: ref_23 article-title: Carotid atherosclerotic plaque characteristics are associated with microembolization during carotid endarterectomy and procedural outcome publication-title: Stroke doi: 10.1161/01.STR.0000173153.51295.ee – volume: 135 start-page: e146 year: 2017 ident: ref_1 article-title: Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association publication-title: Circulation doi: 10.1161/CIR.0000000000000485 – volume: 62 start-page: 2293 year: 2016 ident: ref_14 article-title: Increased Number of Mast Cells in Atherosclerotic Lesions Correlates with the Presence of Myeloid but not Plasmacytoid Dendritic Cells as well as Pro-inflammatory T Cells publication-title: Clin. Lab. doi: 10.7754/Clin.Lab.2016.160517 – volume: 315 start-page: 341 year: 2006 ident: ref_18 article-title: Mast cell activation by lipoproteins publication-title: Methods Mol. Biol. – volume: 235 start-page: 196 year: 2014 ident: ref_38 article-title: Vascular neuropeptide Y contributes to atherosclerotic plaque progression and perivascular mast cell activation publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2014.04.025 – volume: 17 start-page: 28 year: 2013 ident: ref_8 article-title: Role of mast cell chymase and tryptase in the progression of atherosclerosis: Study in 44 autopsied cases publication-title: Ann. Diagn. Pathol. doi: 10.1016/j.anndiagpath.2012.04.007 – volume: 97 start-page: 311 year: 2013 ident: ref_21 article-title: Complement factor C5a as mast cell activator mediates vascular remodelling in vein graft disease publication-title: Cardiovasc. Res. doi: 10.1093/cvr/cvs312 – volume: 46 start-page: 456 year: 2014 ident: ref_31 article-title: Immunoglobulin E (IgE) and ischemic heart disease. Which came first, the chicken or the egg? publication-title: Ann. Med. doi: 10.3109/07853890.2014.927714 – volume: 2 start-page: 643 year: 2015 ident: ref_4 article-title: Mast cells in human and experimental cardiometabolic diseases publication-title: Nat. Rev. Cardiol. doi: 10.1038/nrcardio.2015.117 – volume: 72 start-page: 20 year: 2014 ident: ref_34 article-title: Allergic asthma accelerates atherosclerosis dependent on Th2 and Th17 in apolipoprotein E deficient mice publication-title: J. Mol. Cell. Cardiol. doi: 10.1016/j.yjmcc.2014.02.005 – volume: 17 start-page: 611 year: 2006 ident: ref_9 article-title: Desquamation of human coronary artery endothelium by human mast cell proteases: Implications for plaque erosion publication-title: Coron. Artery Dis. doi: 10.1097/01.mca.0000224420.67304.4d – volume: 92 start-page: 1084 year: 1995 ident: ref_6 article-title: Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction publication-title: Circulation doi: 10.1161/01.CIR.92.5.1084 – volume: 121 start-page: 3564 year: 2011 ident: ref_16 article-title: IgE stimulates human and mouse arterial cell apoptosis and cytokine expression and promotes atherogenesis in Apoe−/− mice publication-title: J. Clin. Investig. doi: 10.1172/JCI46028 – ident: ref_12 doi: 10.1371/journal.pone.0060960 – volume: 89 start-page: 244 year: 2011 ident: ref_13 article-title: Mast cell chymase inhibition reduces atherosclerotic plaque progression and improves plaque stability in ApoE−/− mice publication-title: Cardiovasc Res. doi: 10.1093/cvr/cvq260 – volume: 88 start-page: 6382 year: 1991 ident: ref_27 article-title: Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.88.14.6382 – volume: 35 start-page: 265 year: 2015 ident: ref_2 article-title: Mast cells as effectors in atherosclerosis publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/ATVBAHA.114.303570 – volume: 34 start-page: 3699 year: 2013 ident: ref_15 article-title: Mast cells in human carotid atherosclerotic plaques are associated with intraplaque microvessel density and the occurrence of future cardiovascular events publication-title: Eur. Heart J. doi: 10.1093/eurheartj/eht186 – volume: 170 start-page: 245 year: 1989 ident: ref_26 article-title: Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines publication-title: J. Exp. Med. doi: 10.1084/jem.170.1.245 – volume: 268 start-page: 152 year: 2018 ident: ref_36 article-title: Systemic mastocytosis associates with cardiovascular events despite lower plasma lipid levels publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2017.11.030 – volume: 388 start-page: 39 year: 2015 ident: ref_40 article-title: Anti-IgE therapy: Clinical utility and mechanistic insights publication-title: Curr. Top. Microbiol. Immunol. – volume: 251 start-page: 355 year: 2016 ident: ref_17 article-title: Serum IgE levels are associated with coronary artery disease severity publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2016.05.020 – volume: 31 start-page: 842 year: 2013 ident: ref_20 article-title: Oxidized low-density lipoprotein induces inflammatory responses in cultured human mast cells via Toll-like receptor 4 publication-title: Cell. Physiol. Biochem. doi: 10.1159/000350102 – volume: 191 start-page: 2871 year: 2013 ident: ref_28 article-title: The tetraspanin CD63 is required for efficient IgE-mediated mast cell degranulation and anaphylaxis publication-title: J. Immunol. doi: 10.4049/jimmunol.1202323 – volume: 49 start-page: 203 year: 1996 ident: ref_30 article-title: IgE predicts future nonfatal myocardial infarction in men publication-title: J. Clin. Epidemiol. doi: 10.1016/0895-4356(95)00548-X |
| SSID | ssj0000816105 |
| Score | 2.2678282 |
| Snippet | The presence of mast cells in human atherosclerotic plaques has been associated with adverse cardiovascular events. Mast cell activation, through the classical... |
| SourceID | doaj pubmedcentral proquest pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 334 |
| SubjectTerms | Arteriosclerosis Atherosclerosis Atherosclerosis - pathology CD63 antigen Cell activation Cells, Cultured Flow cytometry Flow Cytometry - methods Hemorrhage Histamine Histology Human subjects Humans Immunoglobulin E Immunoglobulin E - metabolism Immunohistochemistry Inflammation mast cell Mast cells Mast Cells - metabolism Mast Cells - pathology plaque stability Plaque, Atherosclerotic - pathology Plaques Population Proto-Oncogene Proteins c-kit - metabolism Receptors, IgE - metabolism Surgery Tetraspanin 30 - metabolism Tryptase Veins & arteries |
| SummonAdditionalLinks | – databaseName: Biological Science Database dbid: M7P link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR27btRAcAQBJJqEN4aAFgkqZMXxel8VSk6cKEKUAqR01j7JScEOZwd0f5_Ztc_kIqChcWGP1rue98MzAG-p2i8Lah0Sb2nzSkuVa-1oHpN4KA25lCG1zD8Sx8fy9FSdjAG3biyrXMvEJKhda2OMfA8dGSQ-wRn7cPEjj1OjYnZ1HKFxG-7ELgk0le6dTDGWOFQC7Yeh3p2id78Xo-GdRMKltNrQRKlh_5-szJvFkte0z3znf_f9ALZHu5McDITyEG755hHcGyZRrh7D0fy8_UVmq7797vvlKj9E5ebIbOrmPPysSdpAPuuuJ7N4QLJoSMoBkINoRbYdLozXRfcEvs4_fpl9ysdBC7mthOxz5oMPIWhnqXaSBs2MQS2mLdvnglodlJOMW1oWnmvjUA7YKnhhjHOCGy7pU9hq2sY_ByLRQ7GlcEJJV6HvpkuDi-qYTGSqCiKD9-uPXtuxC3kchnFeozcSUVRfR1EG7yboi6H7xl_gDiP-JpjYMzvdaJff6pEFa8OoURaP4YKvnLbKOoveHGfOlRz9xgx21xisR0bu6t_oy-DN9BhZML5eN769RJiyEIpF0ZfBs4FYpp3QQolo1WUgNshoY6ubT5rFWWrzzRmaU5y_-Pe2XsJ9tOFSgqtQu7DVLy_9K7hrf_aLbvk68cMVH8AX2w priority: 102 providerName: ProQuest |
| Title | Flow Cytometry-Based Characterization of Mast Cells in Human Atherosclerosis |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/30970663 https://www.proquest.com/docview/2548327655 https://www.proquest.com/docview/2207955787 https://pubmed.ncbi.nlm.nih.gov/PMC6523866 https://doaj.org/article/b53b9c6c3dfe4dac9cdc26065dd26871 |
| Volume | 8 |
| WOSCitedRecordID | wos000467304300048&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ - Directory of Open Access Journals customDbUrl: eissn: 2073-4409 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000816105 issn: 2073-4409 databaseCode: DOA dateStart: 20120101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2073-4409 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000816105 issn: 2073-4409 databaseCode: M~E dateStart: 20120101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 2073-4409 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000816105 issn: 2073-4409 databaseCode: M7P dateStart: 20120301 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central (New) (NC LIVE) customDbUrl: eissn: 2073-4409 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000816105 issn: 2073-4409 databaseCode: BENPR dateStart: 20120301 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Publicly Available Content Database customDbUrl: eissn: 2073-4409 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000816105 issn: 2073-4409 databaseCode: PIMPY dateStart: 20120301 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrR1da9RAcNCq4IvUrxpbjxX0SULTbPbrsXfcodAeQRTOp7DZDzyoSbmkyr34251N0nAnii--5CE7bCaz87k7OwPwhqqzNKHGIvOmJs60VLHWlsbhEA-1IZfSdyXzL8RyKVcrle-0-go5YX154J5wpyWjpTLcUOtdZrVRxhr0wTmzNuWyuz2eotezE0x1OliiJ5OwPtOdYlx_GvbBG4ksS2m2Z4O6Uv1_8i9_T5PcsTuLQ3g0OIzkvEf0Mdxx1RN40LeQ3D6Fi8VV_YPMtm39zbWbbTxFq2TJbCzD3N-yJLUnl7ppySzgR9YV6TbvyXlw_-oGJ8bnunkGnxfzT7P38dAhITaZkG3MnHfee20N1VZSr1lZovnRhp1xQY32ykqGtEsTx3VpUYBN5p0oS2sFL7mkz-Ggqiv3AojE0MKkwgolbYZBl05LnFSHU0CmMi8ieHdLs8IM5cNDF4urAsOIQOFil8IRvB2hr_uyGX-BmwbyjzCh2HX3AlmgGFig-BcLRHByu3jFIIFNgYEvKivBGYvg9TiMshM-rytX3yBMmgjFgs6K4Khf6xETmigR3LEIxB4X7KG6P1Ktv3b1uTkG95Lzl__j347hIbpo3flVok7goN3cuFdw33xv181mAnfFSk7g3nS-zD9OOhGYhOzVPDx_znEk_3CZf_kFlbIRSw |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VAoILz0IDBYxETyhqGsevA0LtwqpVt6seitRbcPyAlUrSblKq_VP8RsbJbugi4NYDlxySkePH5_E3HnsG4A1V22lCjUXwpibOtFSx1pbGwYmH2pBL6duQ-SMxHsuTE3W0Aj8Wd2HCscqFTmwVta1M2CPfQkMGwSc4Y-_PzuOQNSp4VxcpNDpYHLjZJZps9bv9Dzi-m2k6_Hg82IvnWQVikwnZxMx5573X1lBtJfWaFQWqbG3YNhfUaK-sZNzQNHFcFxZBbzLvRFFYK3jBJcVyb8BNpBGpbI8KHvV7OiGJBfKV7nw9pSrZCrvvtcSJQmm2tPK1CQL-xGp_P5x5ZbUb3v_f-ukB3JvzarLTTYSHsOLKR3C7y7Q5ewyj4Wl1SQazpvrmmuks3sXF25JBH626u4xKKk8Odd2QQehQMilJ6-MgO4ElVzUWjM9JvQafrqUpT2C1rEq3DkSiBWZSYYWSNkPbVKcFFqqDs5SpzIsI3i4GOTfzKOsh2cdpjtZWgER-FRIRbPbSZ110kb_I7Qa89DIhJnj7opp-yecqJi8YLZTBZljvMquNMtagtcqZtSlHuziCjQVi8rmiqvNfcIngdf8ZVUz4vS5ddYEyaSIUC6o9gqcdOPua0ESJwFojEEuwXarq8pdy8rUNY84Z0kXOn_27Wq_gzt7x4Sgf7Y8PnsNd5KutMy9RG7DaTC_cC7hlvjeTevqynYsEPl83qH8C4xV6Kg |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6V8hAX3o9AgSDRE4o2jePXAaF2y4qq29UeQOotOH7ASiUpm5Rq_xq_jnFedBFw64FLDsnI8ePz5xmPPQPwisidJCbaIHgTHaVKyEgpQyLvxEM2ZEK4JmT-lM9m4vhYzjfgR38Xxh-r7DmxIWpTar9HPkJDBsHHGaUj1x2LmO9P3p5-i3wGKe9p7dNptBA5tKtzNN-qNwf7ONbbSTJ592H8PuoyDEQ65aKOqHXWOaeMJsoI4hTNc6RvpekO40QrJ42gTJMktkzlBieATp3leW4MZzkTBMu9Ald5yhpSOOLzYX_HJ7RA3aU9a0-IjEd-J74SOGkISddWwSZZwJ803N8Pal5Y-Sa3_-c-uwO3On073G0nyF3YsMU9uN5m4Fzdh-nkpDwPx6u6_Grr5Sraw0XdhOMhinV7STUsXXikqjoc-84NF0XY-D7CXa89lxUWjM9F9QA-XkpTHsJmURb2MYQCLTOdcMOlMCnarCrJsVDlnahUpo4H8Lof8Ex30dd9EpCTDK0wD4_sIjwC2B6kT9uoI3-R2_PYGWR8rPDmRbn8nHXUk-WU5FJjM4yzqVFaaqPRimXUmIShvRzAVo-erCOwKvsFnQBeDp-RevzvVWHLM5RJYi6pp_wAHrVAHWpCYsm9NhsAX4PwWlXXvxSLL014c0ZRjWTsyb-r9QJuIJaz6cHs8CncRDW28fHFcgs26-WZfQbX9Pd6US2fN9MyhE-Xjemf_rmC6A |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Flow+Cytometry-Based+Characterization+of+Mast+Cells+in+Human+Atherosclerosis&rft.jtitle=Cells+%28Basel%2C+Switzerland%29&rft.au=Eva+Kritikou&rft.au=Marie+A.C.+Depuydt&rft.au=Margreet+R.+de+Vries&rft.au=Kevin+E.+Mulder&rft.date=2019-04-09&rft.pub=MDPI+AG&rft.eissn=2073-4409&rft.volume=8&rft.issue=4&rft.spage=334&rft_id=info:doi/10.3390%2Fcells8040334&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_b53b9c6c3dfe4dac9cdc26065dd26871 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2073-4409&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2073-4409&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2073-4409&client=summon |